Literature DB >> 28552518

Systemic Treatments in Soft Tissue Sarcomas.

H Hatcher1, C Benson2, T Ajithkumar3.   

Abstract

Systematic treatment of adult-type soft tissue sarcoma is evolving. Its role in the neoadjuvant setting is currently experimental, whereas the data on adjuvant chemotherapy are inconclusive. Nevertheless, in clinical practice, neoadjuvant and adjuvant chemotherapy may be considered on an individual basis after multidisciplinary discussion. Systemic therapy has a well-established role in the management of locally advanced and metastatic disease and histology-based treatment approaches are being studied. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Soft tissue sarcoma; systemic therapy; targeted agents

Mesh:

Year:  2017        PMID: 28552518     DOI: 10.1016/j.clon.2017.05.002

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  2 in total

1.  Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes.

Authors:  Eisuke Kobayashi; Yoichi Naito; Naofumi Asano; Aiko Maejima; Makoto Endo; Shunji Takahashi; Yasunori Megumi; Akira Kawai
Journal:  Jpn J Clin Oncol       Date:  2019-10-01       Impact factor: 3.019

2.  Clear cell sarcoma of soft tissue in pleural cavity: A case report.

Authors:  Yang-Tian Chen; Zhi Yang; Huan Li; Chen-Hui Ni
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.